News Adcetris falls victim to NICE’s Cancer Drugs Fund clear-out More CDF legacy products likely to face same fate
Views & Analysis PPRS and devolution: over £60m to Greater Manchester? Does the local NHS in England get its fair share of PPRS money?
News NHS England offers £100m to develop centres of digital excel... New centres will lead adoption of digital technology
News NHS England extends deadline for med tech, digital innovatio... Innovation and Technology tariff deadline extended to 16 August
News Disappointment for UK pharma as Life Sciences minister role ... No successor for Freeman, but Office for Life Sciences to remain
Views & Analysis Access to cancer drugs: planning for every outcome New UK oncology drug assessment procedures examined.
News EU clears first drug therapy for rare disease cALD Neuraxpharm and Minoryx' Nezglyal has become the first approved drug therapy in the EU for rare neurodegenerative disease cALD.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
